Homology Medicines, Inc. (FIXX)の価格はいくらですか

Homology Medicines, Inc. (FIXX)の価格は$0.9347です

Homology Medicines, Inc. (FIXX)の時価総額は何ですか

Homology Medicines, Inc. (FIXX)の時価総額は$300.42Kです

Homology Medicines, Inc.（FIXX）の株価履歴

Homology Medicines, Inc. is a biotechnology firm dedicated to genetic therapeutics, striving to enhance the well-being of patients battling rare inherited disorders. The company leverages its unique platform, which employs adeno-associated virus vectors (AAVHSCs) originating from human hematopoietic stem cells, to introduce genetic treatments directly into the body. This approach facilitates either gene therapy or nuclease-free gene editing solutions for a range of genetic ailments. Crucially, Homology's diverse collection of AAVHSCs enables the precise targeting of multiple disease-affected tissues—such as the liver, central and peripheral nervous systems, bone marrow, heart, skeletal muscles, and eyes—all from a single administration. The leading candidate in their pipeline, HMI-102, is a gene therapy undergoing the Phase 2 pheNIX clinical trial, intended for adult patients with phenylketonuria (PKU). Beyond this, their development portfolio includes HMI-103 for pediatric PKU, HMI-202 targeting metachromatic leukodystrophy, HMI-203 for mucopolysaccharidosis type II, and HMI-104 designed to address paroxysmal nocturnal hemoglobinuria. Established in 2015, Homology Medicines, Inc. maintains its corporate headquarters in Bedford, Massachusetts.

年	パフォーマンス
2024	62.24%
2023	-59.20%
2022	-67.95%
2021	-61.63%
2020	-44.79%
2019	-12.55%
2018	0.00%

年

パフォーマンス

2024

62.24%

2023

-59.20%

2022

-67.95%

2021

-61.63%

2020

-44.79%

2019

-12.55%

2018

0.00%

企業	株価	変化率 1年%	国
Vertex Pharmaceuticals Incorporated VRTX.US	$517.18	32.51%	US
Argenx SE ARGX.US	$857.76	31.47%	NL
Lonza Group AG LONN.SW	$744.96	9.07%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.07K	-6.09%	KR
UCB S.A. UCB.BR	$259.89	14.81%	BE

企業

株価

変化率 1年%

国